Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $697.04 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esperion Therapeutics, Inc. | $353.01 | 3 | $0 (2021) |
| Amgen Inc. | $308.67 | 3 | $0 (2021) |
| Boston Scientific Corporation | $21.37 | 1 | $0 (2020) |
| Allergan, Inc. | $13.99 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $422.52 | 4 | Amgen Inc. ($308.67) |
| 2020 | $274.52 | 4 | Esperion Therapeutics, Inc. ($239.16) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $98.62 | General |
| Category: Neuroscience | ||||||
| 06/24/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $110.57 | General |
| Category: Cardiology | ||||||
| 05/27/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $113.85 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/15/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $99.48 | General |
| Category: Cardiology | ||||||
| 11/13/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/24/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $117.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/15/2020 | Boston Scientific Corporation | GENERAL - DBS (Device) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: DBS | ||||||
About Dr. Joseph Zerga, M.D
Dr. Joseph Zerga, M.D is a Neurology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598710139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Zerga, M.D has received a total of $697.04 in payments from pharmaceutical and medical device companies, with $422.52 received in 2021. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($697.04).
Practice Information
- Specialty Neurology
- Location Lexington, KY
- Active Since 05/23/2006
- Last Updated 08/19/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598710139
Products in Payments
- NEXLIZET (Drug) $353.01
- Repatha (Biological) $210.05
- Aimovig (Biological) $98.62
- GENERAL - DBS (Device) $21.37
- UBRELVY (Drug) $13.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lexington
Dr. Nicole Everman, M.d, M.D
Neurology — Payments: $506,986
Toufic Fakhoury, Md, MD
Neurology — Payments: $393,864
Larry Goldstein, Md, MD
Neurology — Payments: $28,134
Jagannadha Avasarala, Md, Phd, MD, PHD
Neurology — Payments: $26,770
Fred Odago, Md, MD
Neurology — Payments: $22,752
Sharoon Qaiser, M.d, M.D
Neurology — Payments: $19,615